PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Pharmacology

• Publication date

  2013-09-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2013.05.021PMID 23791613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Roles of Cardiomyocyte and Macrophage Peroxisome Proliferator–Activated Receptor γ in Cardiac Fibrosis

  2008cited by this paper
• Agonists at PPAR‐γ suppress angiotensin II‐induced production of plasminogen activator inhibitor‐1 and extracellular matrix in rat cardiac fibroblasts

  2008cited by this paper
• PPARγ Gene Transfer Sustains Apoptosis, Inhibits Vascular Smooth Muscle Cell Proliferation, and Reduces Neointima Formation After Balloon Injury in Rats

  2006cited by this paper
• PPARs and other nuclear receptors in inflammation.

  2006cited by this paper
• Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes

  2006cited by this paper
• Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction.

  2006cited by this paper
• Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics s⃞ Published, JLR Papers in Press, April 3, 2006.

  2006cited by this paper
• Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.

  2004cited by this paper
• Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation.

  2003cited by this paper
• The mechanisms of action of PPARs.

  2002cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Peroxisome proliferator-activated receptor (PPAR)-γ expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-γ activator troglitazone☆

  2000cited by this paper
• Cardiac remodeling by fibrous tissue after infarction in rats.

  2000cited by this paper
• Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.

  2000cited by this paper
• Cell cycle‐dependent variations in c‐Jun and JunB phosphorylation: a role in the control of cyclin D1 expression

  2000cited by this paper
• Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.

  1999cited by this paper
• The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation.

  1999cited by this paper
• Myofibroblasts and local angiotensin II in rat cardiac tissue repair.

  1997cited by this paper
• Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.

  1997cited by this paper
• Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.

  1997cited by this paper
• An AP-1-like motif in the first intron of human Proα1(I) collagen gene is a critical determinant of its transcriptional activity

  1992cited by this paper
• Primary response genes induced by growth factors and tumor promoters.

  1991cited by this paper
• The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

  1991cited by this paper
• Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains.

  1989cited by this paper
• Characterization of the promoter region of the human transforming growth factor-beta 1 gene.

  1989cited by this paper
• Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers.

  1989cited by this paper

• Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders

  2025cites this paper
• AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failure.

  2024cites this paper
• Application of Compounds with Anti‐Cardiac Fibrosis Activity: A Review

  2024cites this paper
• Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway

  2024cites this paper
• Moderate exercise mitigates cardiac dysfunction and injury induced by cyclosporine A through activation of the PGI2 / PPAR-γ signaling pathway

  2023cites this paper
• An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed

  2023cites this paper
• Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy

  2023cites this paper
• Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling

  2021cites this paper
• Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms.

  2021cites this paper
• AMP-activated protein kinase: a remarkable contributor to preserve a healthy heart against ROS injury.

  2021cites this paper
• Citri reticulatae Pericarpium attenuates Ang II-induced pathological cardiac hypertrophy via upregulating peroxisome proliferator-activated receptors gamma

  2020cites this paper
• Targeting peroxisome proliferator-activated receptors: A new strategy for the treatment of cardiac fibrosis.

  2020cites this paper
• Rosiglitazone‐dependent dissociation of HuR from PPAR‐γ regulates adiponectin expression at the posttranscriptional level

  2019cites this paper
• Nitric oxide balances osteoblast and adipocyte lineage differentiation via the JNK/MAPK signaling pathway in periodontal ligament stem cells

  2018cites this paper
• Chrysin attenuates interstitial fibrosis and improves cardiac function in a rat model of acute myocardial infarction

  2018cites this paper
• Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes.

  2017cites this paper
• Cardiac mesenchymal progenitors differentiate into adipocytes via Klf4 and c-Myc

  2016cites this paper
• PPAR-γ is involved in the protective effect of 2,3,4',5-tetrahydroxystilbene-2-O-beta-D-glucoside against cardiac fibrosis in pressure-overloaded rats.

  2016cites this paper
• Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1/2 and p38-MAPK pathways.

  2016cites this paper
• Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?

  2016cites this paper
• TATA boxes in gene transcription and poly (A) tails in mRNA stability: New perspective on the effects of berberine

  2015cites this paper
• Abietic acid inhibits UVB‐induced MMP‐1 expression in human dermal fibroblast cells through PPARα/γ dual activation

  2015cites this paper
• Prostacyclin Analogue Beraprost Inhibits Cardiac Fibroblast Proliferation Depending on Prostacyclin Receptor Activation through a TGF β-Smad Signal Pathway

  2014cites this paper
• Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts

  2014cites this paper
• Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.

  2013cites this paper
• Review Article Peroxisome Proliferator-activated Receptor-í Μí»¾ Is Critical to Cardiac Fibrosis

  year unknowncites this paper